1. Home
  2. ABCL vs OPK Comparison

ABCL vs OPK Comparison

Compare ABCL & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.51

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo OPKO Health Inc.

OPK

OPKO Health Inc.

HOLD

Current Price

$1.15

Market Cap

921.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
OPK
Founded
2012
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
921.2M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
ABCL
OPK
Price
$3.51
$1.15
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
$7.75
$2.03
AVG Volume (30 Days)
2.3M
2.4M
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
N/A
EPS
N/A
N/A
Revenue
$75,128,000.00
$606,879,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$25.44
$4.24
P/E Ratio
N/A
N/A
Revenue Growth
160.56
N/A
52 Week Low
$1.89
$1.10
52 Week High
$6.52
$1.60

Technical Indicators

Market Signals
Indicator
ABCL
OPK
Relative Strength Index (RSI) 53.38 45.32
Support Level $3.37 $1.12
Resistance Level $3.57 $1.27
Average True Range (ATR) 0.15 0.04
MACD 0.01 -0.00
Stochastic Oscillator 65.63 36.00

Price Performance

Historical Comparison
ABCL
OPK

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Share on Social Networks: